<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7278221\results\search\drug\results.xml">
  <result pre="trial to validate four drugs especially in combinations, including ritonavir/lopinavir," exact="lopinavir" post="and ritonavir with interferon-beta, chloroquine and/or remdesivir. Several clinical"/>
  <result pre="validate four drugs especially in combinations, including ritonavir/lopinavir, lopinavir and" exact="ritonavir" post="with interferon-beta, chloroquine and/or remdesivir. Several clinical trials, over"/>
  <result pre="especially in combinations, including ritonavir/lopinavir, lopinavir and ritonavir with interferon-beta," exact="chloroquine" post="and/or remdesivir. Several clinical trials, over 1673, have been"/>
  <result pre="significant clinical trials. Conditions Numbers of enrollment (estimated) Results Reference/trials" exact="Hydroxychloroquine" post="Mild 30 Negative 39 Hydroxychloroquine Mild/severe 62 Positive 41"/>
  <result pre="of enrollment (estimated) Results Reference/trials Hydroxychloroquine Mild 30 Negative 39" exact="Hydroxychloroquine" post="Mild/severe 62 Positive 41 Hydroxychloroquine Symptomatic disease 510 Ongoing"/>
  <result pre="Hydroxychloroquine Mild 30 Negative 39 Hydroxychloroquine Mild/severe 62 Positive 41" exact="Hydroxychloroquine" post="Symptomatic disease 510 Ongoing https://clinicaltrials.gov/ct2/show/NCT04332991 Hydroxychloroquine Prevention 40,000 Ongoing"/>
  <result pre="Mild/severe 62 Positive 41 Hydroxychloroquine Symptomatic disease 510 Ongoing https://clinicaltrials.gov/ct2/show/NCT04332991" exact="Hydroxychloroquine" post="Prevention 40,000 Ongoing https://clinicaltrials.gov/ct2/show/NCT04303507 Lopinavir/ritonavir Severe 199 Negative 51"/>
  <result pre="Mild 80 Ongoing https://clinicaltrials.gov/ct2/show/NCT04340232 Convalescent plasma Severe 10 Positive 63" exact="Chloroquine" post="and hydroxychloroquine Chloroquine (CQ) and its related drug hydroxychloroquine"/>
  <result pre="Ongoing https://clinicaltrials.gov/ct2/show/NCT04340232 Convalescent plasma Severe 10 Positive 63 Chloroquine and" exact="hydroxychloroquine" post="Chloroquine (CQ) and its related drug hydroxychloroquine (HCQ), both"/>
  <result pre="https://clinicaltrials.gov/ct2/show/NCT04340232 Convalescent plasma Severe 10 Positive 63 Chloroquine and hydroxychloroquine" exact="Chloroquine" post="(CQ) and its related drug hydroxychloroquine (HCQ), both of"/>
  <result pre="63 Chloroquine and hydroxychloroquine Chloroquine (CQ) and its related drug" exact="hydroxychloroquine" post="(HCQ), both of which are well-known for their effectiveness"/>
  <result pre="for now. Moreover, the combination of HCQ with antibiotic drug" exact="azithromycin" post="has been reported to have added benefit. Since azithromycin"/>
  <result pre="drug azithromycin has been reported to have added benefit. Since" exact="azithromycin" post="is known to reversibly binds to the 50S ribosomal"/>
  <result pre="effect is not known. It is also not known whether" exact="azithromycin" post="synergize with HCQ to provide better antiviral activity. A"/>
  <result pre="active anti-retroviral therapy (HAART). The combination of LPV/r with additional" exact="ribavirin" post="was reported to be able to reduce the risk"/>
  <result pre="we recently find that administration of LPV/r along with interferon" exact="alpha" post="inhaling was not associated with faster virological clearance or"/>
  <result pre="effective in treating COVID-19. Remdesivir Another promising drug is the" exact="adenosine" post="analog remdesivir (GS-5734) that is incorporated into nascent viral"/>
  <result pre="viral entry4â€&quot;6 showed the specificity of the serine protease inhibitor" exact="camostat" post="mesylate as an active compond against TMPRSS2 which is"/>
  <result pre="the priming of the viral S protein. Clinical trial of" exact="camostat" post="mesylate or its derivatives are therefore required4â€&quot;6. Ivermectin The"/>
  <result pre="required4â€&quot;6. Ivermectin The recent work on the FDA-approved anti-parasitic compound" exact="ivermectin" post="seems extremely powerful even though so far it is"/>
  <result pre="report of 1014 cases. Radiology, 10.1148/radiol.2020200642 (2020). 37.WangMet al.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
  <result pre="vitro antiviral activity and projection of optimized dosing design of" exact="hydroxychloroquine" post="for the treatment of severe acute respiratory syndrome coronavirus"/>
  <result pre="10.1093/cid/ciaa237 (2020). 39.Chen, J. et al. A pilot study of" exact="hydroxychloroquine" post="in treatment of patients with common coronavirus disease-19 (COVID-19)."/>
  <result pre="S. &amp;amp; Saffaei, A. Aminoquinolines against coronavirus disease 2019 (COVID-19):" exact="chloroquine" post="or hydroxychloroquine. Int. J. Antimicrob. Agents55,105945 (2020). 41.Chen, Z."/>
  <result pre="J. Antimicrob. Agents55,105945 (2020). 41.Chen, Z. et al. Efficacy of" exact="hydroxychloroquine" post="in patients with COVID-19: results of a randomized clinical"/>
  <result pre="at https://www.medrxiv.org/content/10.1101/2020.03.22.20040758v3 (2020) 42.Juurlink, D. N. Safety considerations with chloroquine," exact="hydroxychloroquine" post="and azithromycin in the management of SARS-CoV-2 infection. CMAJ10.1503/cmaj.200528"/>
  <result pre="(2020) 42.Juurlink, D. N. Safety considerations with chloroquine, hydroxychloroquine and" exact="azithromycin" post="in the management of SARS-CoV-2 infection. CMAJ10.1503/cmaj.200528 (2020). 43.Molina,"/>
  <result pre="rapid antiviral clearance or clinical benefit with the combination of" exact="hydroxychloroquine" post="and azithromycin in patients with severe COVID-19 infection. Med."/>
  <result pre="clearance or clinical benefit with the combination of hydroxychloroquine and" exact="azithromycin" post="in patients with severe COVID-19 infection. Med. Mal. Infect."/>
  <result pre="Med. Mal. Infect. 10.1016/j.medmal.2020.03.006 (2020). 44.Principi, N. &amp;amp; Esposito, S." exact="Chloroquine" post="or hydroxychloroquine for prophylaxis of COVID-19. Lancet Infect. Dis."/>
  <result pre="Infect. 10.1016/j.medmal.2020.03.006 (2020). 44.Principi, N. &amp;amp; Esposito, S. Chloroquine or" exact="hydroxychloroquine" post="for prophylaxis of COVID-19. Lancet Infect. Dis. 10.1016/s1473-3099(20)30296-6 (2020)."/>
  <result pre="matched cohort studyHong Kong Med. J.2003939940614660806 46.KimUJWonEJKeeSJJungSIJangHCCombination therapy with lopinavir/ritonavir," exact="ribavirin" post="and interferon-a for Middle East respiratory syndromeAntivir. Ther.20162145545926492219 47.MinCKet"/>
  <result pre="Wang, Y. &amp;amp; Wang, G. Q. A systematic review of" exact="lopinavir" post="therapy for SARS coronavirus and MERS coronavirusâ€&quot;a possible reference"/>
  <result pre="Remdesivir accelerates recovery from advanced COVID-19. https://www.nih.gov/news-events/news-releases/nih-clinical-trial-shows-remdesivir-accelerates-recovery-advanced-covid-19. 61.CalyLDruceJDCattonMGJansDAWagstaffKMThe FDA-approved drug" exact="ivermectin" post="inhibits the replication of SARS-CoV-2 in vitroAntiviral Res.202017810478732251768 62.Shen,"/>
  <result pre="Dis.200524444615616839 65.SooYOYet al.Retrospective comparison of convalescent plasma with continuing high-dose" exact="methylprednisolone" post="treatment in SARS patientsClin. Microbiol. Infect.20041067667815214887 66.HungIFNet al.Convalescent plasma"/>
  <result pre="severe 2019-nCoV pneumoniaSignal Transduct. Target. Ther.202051832296012 80.SchrezenmeierEDÃ¶rnerTMechanisms of action of" exact="hydroxychloroquine" post="and chloroquine: implications for rheumatologyNat. Rev. Rheumatol.20201615516632034323 81.PatonNIet al.Effects"/>
  <result pre="and chloroquine: implications for rheumatologyNat. Rev. Rheumatol.20201615516632034323 81.PatonNIet al.Effects of" exact="hydroxychloroquine" post="on immune activation and disease progression among HIV-infected patients"/>
 </snippets>
</snippetsTree>
